Stay updated on Bictegravir vs Dolutegravir in HIV/HepB Co-Infection Clinical Trial

Sign up to get notified when there's something new on the Bictegravir vs Dolutegravir in HIV/HepB Co-Infection Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Bictegravir vs Dolutegravir in HIV/HepB Co-Infection Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    Added a dedicated Locations section listing Florida and Georgia, and removed the separate Florida Locations and Georgia Locations blocks. Revision updated to v3.3.3.
    Difference
    0.3%
    Check dated 2025-12-23T21:21:28.000Z thumbnail image
  2. Check
    11 days ago
    No Change Detected
  3. Check
    18 days ago
    No Change Detected
  4. Check
    33 days ago
    Change Detected
    Summary
    Added a note that PubMed publications are automatically filled from PubMed and may not be about the study; updated revision to v3.3.2. Removed the previous wording stating that publications come from PubMed and are automatically created by ClinicalTrials.gov Identifier (NCT Number) and the older revision reference v3.2.0.
    Difference
    0.1%
    Check dated 2025-11-25T10:56:18.000Z thumbnail image
  5. Check
    40 days ago
    Change Detected
    Summary
    Removed the government funding lapse notice from the top of the page.
    Difference
    0.4%
    Check dated 2025-11-18T06:59:22.000Z thumbnail image
  6. Check
    54 days ago
    Change Detected
    Summary
    Results First Posted date (2024-12-27) and updated Study Record Dates were added, and a PubMed publication (Nat Med 2023) is linked. The page now includes the study's enrollment (36) and access to the protocol and consent forms.
    Difference
    0.4%
    Check dated 2025-11-03T21:04:25.000Z thumbnail image
  7. Check
    83 days ago
    Change Detected
    Summary
    - Added a government-funding notice about potential delays and updated operating status guidance, and a major version bump to v3.2.0. - Removed the previous version tag v3.1.0.
    Difference
    2%
    Check dated 2025-10-06T05:30:09.000Z thumbnail image
  8. Check
    90 days ago
    Change Detected
    Summary
    Page updates version from v3.0.2 to v3.1.0 and removes a specific disease resource; otherwise, core content remains unchanged.
    Difference
    0.4%
    Check dated 2025-09-29T03:04:32.000Z thumbnail image

Stay in the know with updates to Bictegravir vs Dolutegravir in HIV/HepB Co-Infection Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Bictegravir vs Dolutegravir in HIV/HepB Co-Infection Clinical Trial page.